Search PubMed⌕ Search

Biomedical subjects

B Richmond

Publications and source records attributed to B Richmond.

21 records · Page 2Linked to original sources
PubMedDate not supplied

Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care.

Bone mineral density (BMD) performed by dual energy x-ray absorptiometry (DEXA) has been used at our institution as a screening test for osteoporosis since 1986. Of 2789 bone densitometry tests done between 1992 and 1996 on women aged 51-75 years, 1743 (62.5%) were ordered by general internists (GIM), endocrinologists (ENDO), rheumatologists (RHEUM), and a metabolic bone disease specialist (MBDS). We compared the percentage of densitometry tests ordered by GIM, ENDO, RHEUM, and MBDS resulting in one of three possible diagnoses (normal, osteopenia, or osteoporosis). Applying the World Health Organization's (WHO) definition of normal (< 1 standard deviation [SD] below the mean for young, adult women), osteopenia (> or = 1 SD-< 2.5 SD below the mean), and osteoporosis (> or = 2.5 SD below the mean), we found that 34% of patients tested between 1992 and 1996 were osteoporotic, 42% were osteopenic, and 24% had normal bone density results. The rate of osteoporosis diagnosis was highest in the MBDS cohort (chi 2 = 9.19, p = 0.002) compared with patients in the other cohorts. To explore trends in management of this condition, a random sample of osteoporotic women aged 51-75 who had densitometry in 1996 (n = 82) was obtained. Review of medical records revealed that 73% were on some form of osteoporosis treatment (bisphosphonate, estrogen, or calcitonin, with or without calcium and vitamin D supplementation). Treatment rates differed significantly, however, by the ordering physician specialty (96% for MBDS, 63% for ENDO, 75% for RHEUM, and 53% for GIM, chi (2)3df = 11.37, p = 0.01). There were no significant differences in selected clinical or demographic characteristics between patients treated by GIM and MBDS. This variation in treatment rates suggests that an opportunity to enhance primary care physicians' recognition and treatment of osteoporosis exists. Making osteoporosis management an educational focus may help narrow differences in practice and improve the effectiveness of a larger number of physicians treating patients with this problem.

Absorptiometry, Photon↗
PubMedDate not supplied

The effects of gender and type of diabetes on HDL-cholesterol.

OBJECTIVE: To investigate the influence of gender and type of Diabetes on plasma lipoproteins and post-heparin plasma lipoprotein lipase and hepatic lipase activities. DESIGN AND PATIENTS: Cross sectional study of 22 lean Type 2 diabetic subjects (11 men, 11 women) individually matched for gender, BMI and HbA1 with 22 Type 1 (C-peptide negative) diabetic subjects. MEASUREMENTS: Samples were taken for fasting lipids and post heparin samples were obtained for estimation of post heparin lipolytic activity. RESULTS: In men, HDL-Cholesterol was higher in Type 1 diabetes [1.56 (range 0.97-2.27) vs 1.07 (0.54-1.78) mmol/l, p = 0.009] and this was reflected in both HDL2-cholesterol [0.42 (0.02-1.36) vs 0.22 (0.01-0.90) mmol/l, p = 0.05] and HDL3-cholesterol [1.00 (0.75-1.51) vs 0.72 (0.53-0.87) mmol/l, p = 0.02] subfractions while serum triglyceride concentrations were similar. Lipoprotein lipase activity was higher in men with Type 1 diabetes [16.2 (6.2-42.4) vs 9.77 (5.6-22.6) mmol/h/l, p = 0.02] while hepatic lipase activities were similar [15.7 (9.3-23.0) vs 14.0 (6.8-24.0) mmol/h/l, NS). In women, there were no significant differences between Type 1 and Type 2 diabetes in triglycerides, HDL-C, HDL2 or HDL3. Lipoprotein lipase activity was higher in Type 1 women [19.3 (14.1-35.7) vs 11.0 (7.2-15.2) mmol/h-1 1-1, p = 0.0006] but lipatic lipase activity was also higher [12.1 (4.8-20.5) vs 7.3 (2.3-21.4) mmol/h-1 1-1, p = 0.023]. CONCLUSION: In non-obese diabetic subjects, men with Type 1 diabetes have higher HDL-cholesterol than those with Type 2 diabetes, possibly due to the action of peripheral insulin on lipoprotein lipase activity, while in women, HDL-cholesterol concentrations were similar in Type 1 and Type 2 subjects possibly because of lowered lipatic lipase activity in Type 2 women which offsets the increased lipoprotein lipase activity of the Type 1 women.

Blood Glucose↗